CVE-2020-10627
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to...
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- High
- Availability
- Low
Exploit likelihood
What each source reports
CVE List Score used
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
- Record
CVE-2020-10627- CVSS 3.1
- 7.3 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L - Weakness
- CWE-284
- Updated
- 2026-11-02
EUVDEUVD-2020-3075
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
- Record
EUVD-2020-3075- CVSS 3.1
- 7.3 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-r26f-v6j2-2h4j
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to...
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
- Record
GHSA-r26f-v6j2-2h4j- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-284
- Updated
- 2026-11-02
NVD
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
- Record
CVE-2020-10627- CVSS 3.1
- 7.3 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L - CVSS 3.1
- 8.1 High
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - CVSS 2.0
- 4.8 Medium
AV:A/AC:L/Au:N/C:P/I:P/A:N - Weakness
- CWE-284
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2020-10627 is a high vulnerability (CVSS 7.3) in Insulet Omnipod Insulin Management System, published December 1, 2021. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.49%, the 42nd percentile. No source names a fixed version.